A new analysis tool identified candidate ALS predisposition genes using external biobank data
Original source
CoCoRV-nf: a powerful and cost-effective tool for rare variant analysis leveraging external biobank sequence data identified new candidate predisposition genes in amyotrophic lateral sclerosis and neuroblastoma. (opens in a new tab)Compass summarised this from the study's abstract.
Study details
- Studied in
- Human
Researchers developed CoCoRV-nf, a workflow for analysing rare genetic variants with sequencing data from external biobanks as controls. They used it with two amyotrophic lateral sclerosis (ALS) case cohorts and data from gnomAD and All of Us, recapturing known genes and identifying additional candidate genes.
Why this matters
The approach could help researchers improve the statistical power of studies searching for genes associated with ALS. The reported genes are candidates from genetic analysis, not confirmed causes or treatment targets, so this does not currently change ALS treatment.
Limitations and context
This is a primary research article describing a computational tool and genetic association analyses. The supplied abstract does not give sample sizes, identify the candidate genes, or describe independent validation. The findings therefore require further study before the candidate genes can be considered established ALS risk or predisposition genes.